✦ LIBER ✦

Safety and Tolerability of Once-Daily OROS® Hydromorphone Extended-Release in Opioid-Tolerant Adults With Moderate-to-Severe Chronic Cancer and Noncancer Pain: Pooled Analysis of 11 Clinical Studies

✍ Scribed by Srinivas R. Nalamachu; Michael Kutch; Martin E. Hale

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sustained Safety and Efficacy of Once-Da

✍ Ute Richarz; Sandra Waechter; Rainer Sabatowski; Leszek Szczepanski; Heinrich Bi 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB

Safety and efficacy of once-daily hydrom

✍ U. Richarz; S. Waechter; R. Sabatowski; L. Szczepanski; H. Binsfeld 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 36 KB

A randomized, double-blind study of OROS

✍ M. Hale; R. Rauck; S. Li; M. Kutch 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 34 KB

Efficacy and tolerability of OROS hydrom

✍ M. Hale; J. Patrick; S. Nalamachu 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 34 KB